Company Filing History:
Years Active: 2010-2015
Title: Peter Kevin Mays: Innovator in Pharmaceutical Preparations
Introduction
Peter Kevin Mays is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical preparations, particularly in the treatment of diseases and disorders of the breast. His innovative approach focuses on formulations that allow for topical or local administration of drugs, enhancing patient comfort and reducing systemic side effects.
Latest Patents
Peter Kevin Mays holds a patent for "Pharmaceutical Preparations For Treatments Of Diseases And Disorders Of The Breast." This patent discloses formulations designed for topical or local administration of drugs directly to the breast or chest. The goal is to achieve a regional or local effect while minimizing systemic drug levels. The preferred embodiments of his invention involve administering drugs to the surface of the breast, areola, or directly to the nipple. These formulations aim to provide increased patient comfort, enhanced bioavailability, and relatively high blood levels in the treated area, all while reducing side effects compared to systemic administration. The formulations may include drugs in the form of micro or nanoparticles, which can be combined with excipients or carriers to modify release rates or enhance absorption. The drug formulation can take the form of a cream, lotion, or foam.
Career Highlights
Peter Kevin Mays is associated with Femmepharma Holding Company, Inc., where he continues to develop innovative pharmaceutical solutions. His work is characterized by a commitment to improving patient outcomes through advanced drug delivery systems.
Collaborations
Peter has collaborated with notable professionals in his field, including Gerianne Tringali Dipiano and John Ziemniak. These collaborations have contributed to the advancement of his research and the development of effective pharmaceutical formulations.
Conclusion
Peter Kevin Mays is a notable inventor whose work in pharmaceutical preparations has the potential to significantly impact the treatment of breast-related diseases and disorders. His innovative formulations represent a step forward in patient care and drug delivery technology.